Cosmos Health Inc. (COSM): who owns it and who trades it
As of Nov 16, 2026, COSM insiders reported 21 purchases worth $1.7M in the last 12 months. The largest buyer was Grigorios Siokas (CEO), with $1.7M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Cosmos Health
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, COSM insiders reported $1.7M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Grigorios Siokas | CEO | Purchase | 349,825 | $0.20 | $70K | Form 4 |
| Jul 29, 2026 | Grigorios Siokas | CEO | Purchase | 766,284 | $0.18 | $138K | Form 4 |
| Jun 16, 2026 | Georgios Terzis | CFO | Purchase | 168,135 | $0.25 | $42K | Form 4 |
| Jun 11, 2026 | Grigorios Siokas | CEO | Purchase | 218,447 | $0.21 | $45.9K | Form 4 |
| Jun 10, 2026 | Grigorios Siokas | CEO | Purchase | 701,447 | $0.23 | $161K | Form 4 |
| Feb 12, 2026 | Grigorios Siokas | CEO | Purchase | 388,532 | $0.37 | $144K | Form 4 |
| Feb 11, 2026 | Grigorios Siokas | CEO | Purchase | 291,262 | $0.41 | $119K | Form 4 |
| Jan 23, 2026 | Grigorios Siokas | CEO | Purchase | 90,325 | $0.50 | $45.2K | Form 4 |
| Jan 20, 2026 | Grigorios Siokas | CEO | Purchase | 353,321 | $0.50 | $177K | Form 4 |
| Jan 14, 2026 | Grigorios Siokas | CEO | Purchase | 493,495 | $0.45 | $222K | Form 4 |
| Jan 12, 2026 | Grigorios Siokas | CEO | Purchase | 113,185 | $0.50 | $56.6K | Form 4 |
| Jan 8, 2026 | Grigorios Siokas | CEO | Purchase | 156,190 | $0.52 | $81.2K | Form 4 |
| Jan 7, 2026 | Grigorios Siokas | CEO | Purchase | 124,880 | $0.52 | $64.9K | Form 4 |
| Jan 6, 2026 | Grigorios Siokas | CEO | Purchase | 133,953 | $0.54 | $72.3K | Form 4 |
| Dec 19, 2025 | Grigorios Siokas | CEO | Purchase | 88,314 | $0.49 | $43.3K | Form 4 |
| Dec 15, 2025 | Grigorios Siokas | CEO | Purchase | 168,472 | $0.42 | $70.8K | Form 4 |
| Nov 28, 2025 | Grigorios Siokas | CEO | Purchase | 76,360 | $0.64 | $48.9K | Form 4 |
| Nov 25, 2025 | Grigorios Siokas | CEO | Purchase | 55,732 | $0.63 | $35.1K | Form 4 |
| Nov 21, 2025 | Grigorios Siokas | CEO | Purchase | 56,080 | $0.68 | $38.1K | Form 4 |
| Nov 20, 2025 | Grigorios Siokas | CEO | Purchase | 51,315 | $0.62 | $31.8K | Form 4 |
| Nov 19, 2025 | Grigorios Siokas | CEO | Purchase | 61,614 | $0.65 | $40K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Grigorios Siokas | Chief Executive Officer, Director, 10% owner | $1.7M | – | Jul 30, 2026 |
| Georgios Terzis | Chief Financial Officer | $42K | – | Jun 16, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
COSM short interest
Low short interest. 1.8% of COSM shares are sold short: about 1 share in 57. Over the last 12 reports the number of shares short went up 82%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.77M COSM shares were sold short, 1.8% of the shares outstanding, down 22.4% from the report before. At the average daily volume of 2.21M shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.77M | 1.76% | -22% | 2.21M | 1.0 |
| Oct 15, 2026 | 2.29M | 2.27% | -11% | 2.93M | 1.0 |
| Sep 30, 2026 | 2.56M | 2.54% | -15% | 5.05M | 1.0 |
| Sep 15, 2026 | 3.02M | 3.00% | -26% | 2.70M | 1.1 |
| Aug 31, 2026 | 4.08M | 4.05% | +7% | 2.76M | 1.5 |
| Aug 14, 2026 | 3.80M | 6.98% | -7% | 2.83M | 1.3 |
| Jul 31, 2026 | 4.08M | 7.50% | -27% | 4.55M | 1.0 |
| Jul 15, 2026 | 5.60M | 10.28% | +18% | 17.81M | 1.0 |
| Jun 30, 2026 | 4.74M | 8.72% | +102% | 15.98M | 1.0 |
| Jun 15, 2026 | 2.34M | 4.31% | +163% | 14.83M | 1.0 |
| May 29, 2026 | 890,287 | 1.64% | -9% | 1.09M | 1.0 |
| May 15, 2026 | 976,746 | 1.92% | +57% | 919,359 | 1.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Cosmos Health company events
Cosmos Health filed 11 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Nov 10, 2026.
- Nov 10, 2026SharesAmended an earlier report. Changed the rights of its shareholders. Filing
- Nov 10, 2026SharesChanged the rights of its shareholders. Filing
- Oct 22, 2026ResultsReleased financial results. Filing
- Oct 9, 2026ResultsReleased financial results. Filing
- Aug 20, 2026ResultsReleased financial results. Filing
- Jul 16, 2026LeadershipAs described under Item 5.07 of this Current Report on Form 8-K, at the Company’s 2026 Annual Meeting of Stockholders held on July 15, 2026, the stockholders of the Company elected the following to serve as directors of the Company until the next Annual Meeting and until their successors are duly… Filing
- Jul 6, 2026AnnouncementThe Board of Directors of Cosmos Health Inc. authorized and approved a share repurchase program for up to $5 million of the currently outstanding shares of the Company’s common stock over a period of 6 months, ending on December 31, 2026, unless extended by the Company. Filing
- May 22, 2026ResultsReleased financial results. Filing
- Apr 16, 2026ResultsReleased financial results. Filing
- Dec 18, 2025ListingCosmos Health Inc. received a non-compliance letter from Nasdaq for its failure to maintain a minimum bid price of $1.00 per share for thirty (30) consecutive business days in accordance with Nasdaq Listing Rule 5550(a)(2). Filing
- Nov 17, 2025ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Cosmos Health financials
Famous investors that hold COSM
2 of the 50 well-known investors we track reported holding COSM in their latest 13F filing. The largest position is Ken Griffin's, worth $24.7K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 57,497 | $24.7K | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 11,200 | $4.8K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named COSM in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 12, 2026 | Bovopoulos Andreas | 13G/A | 8.1% |
| Nov 12, 2026 | Bovopoulos Andreas | 13G/A | 8.1% |
| Oct 30, 2026 | Bovopoulos Andreas | 13G/A | 6.9% |
| Oct 30, 2026 | Bovopoulos Andreas | 13G/A | 6.9% |
| Oct 29, 2026 | Wells Fargo & Company | 13G | 5.1% |
| Oct 29, 2026 | Wells Fargo & Company | 13G | 5.1% |
| Oct 16, 2026 | Bovopoulos Andreas | 13G/A | 6.5% |
| Oct 16, 2026 | Bovopoulos Andreas | 13G/A | 6.5% |
Questions about Cosmos Health Inc. (COSM) stock
Are COSM insiders buying or selling?
In the last 12 months, COSM insiders reported 21 open-market purchases worth $1.7M and no sales. The latest trade was on Jul 30, 2026. See every trade.
What is the short interest in COSM?
As of Oct 30, 2026, 1.77M COSM shares were sold short, 1.8% of the shares outstanding, down 22.4% from the report before. At the average daily volume of 2.21M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold COSM?
2 of the 50 well-known investors we track reported COSM in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $24.7K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.